Cargando…
Reduction of major gastrointestinal bleeding risk with proton pump inhibitor therapy in patients with atrial fibrillation receiving direct oral anticoagulant
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This research was supported by a grant from the Patient-Centered Clinical Research Coordinating Center (PACEN) funded by the Ministry of Health & Welfare, Republic of Korea (grant n...
Autores principales: | Lee, S R, Choi, E K, Lee, S W, Ahn, H J, Kwon, S, Han, K D, Oh, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206908/ http://dx.doi.org/10.1093/europace/euad122.025 |
Ejemplares similares
-
Outcomes associated with sodium glucose co-transporter 2 inhibitors in anticoagulated atrial fibrillation patients
por: Fawzy, A M, et al.
Publicado: (2023) -
Left atrial strain significance in prediction of early atrial fibrillation recurrence after cardioversion and ablation
por: Sabanovic-Bajramovic, N, et al.
Publicado: (2023) -
Predictors and outcomes of late atrial fibrillation following coronary artery bypass grafting
por: Jameie, M, et al.
Publicado: (2023) -
The role of education level in the mortality of hospitalized patients with atrial fibrillation
por: Sztaniszlav, A, et al.
Publicado: (2023) -
Disease awareness and knowledge of stroke- and atrial fibrillation risk factors in cardiovascular patients
por: Engler, D, et al.
Publicado: (2023)